http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106692176-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106692176-B |
| titleOfInvention | Application of miR-342-5p in preparation of medicine for preventing and treating heart disease |
| abstract | The invention discloses application of miR-342-5p in preparation of a medicine for preventing and treating heart diseases, wherein the miR-342-5p has a remarkable heart protection effect, and can relieve myocardial ischemia/reperfusion injury and improve heart functions. The miR-342-5p is an endogenous substance, exists in normal myocardial cells, and has the advantage of safety in preventing and treating heart diseases by regulating the miR-342-5 p. The miR-342-5p plays a role in protecting the heart by down-regulating apoptosis-related proteins caspase9 and JNK2 and activating a myocardial cell survival signal, and has multiple targets and good comprehensive effect. |
| priorityDate | 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.